Carmot Therapeutics Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Carmot Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011853
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Carmot Therapeutics Inc (Carmot Therapeutics) is a biotechnology company which discovers and develops drugs for the treatment of cancer, inflammation and metabolic diseases. The company’s product portfolio encompasses investigational candidates in preclinical trials: peptide-small molecule hybrid compounds that target Nonalcoholic Steatohepatitis (NASH), protein-protein interactions (NEMO/IKK) for the treatment of cancer and inflammation; and GLP-1R/GIPR for treating Type 2 diabetes and obesity. Carmot Therapeutics proprietary technology, Chemotype Evolution applies to identify and optimize innovative drugs for various therapeutic areas. The company works in collaboration with research institutions and companies such as Amgen Inc and Genentech for discovery of new drugs. Carmot Therapeutics is headquartered in San Francisco, California, the US.

Carmot Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Carmot Therapeutics Raises US$0.5 Million In Venture Financing 10
Licensing Agreements 11
Amgen Enters into Licensing Agreement with Carmot Therapeutics 11
Amgen Expands its Licensing Agreement with Carmot Therapeutics 12
Genentech Enters into Licensing Agreement with Carmot Therapeutics 13
Carmot Therapeutics Inc – Key Competitors 14
Carmot Therapeutics Inc – Key Employees 15
Carmot Therapeutics Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Aug 16, 2016: Carmot Therapeutics Appoints Aetna Wun Trombley, Ph.D. to the Board of Directors and Elena Viboch as Director of Business Development and Operations 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Carmot Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Carmot Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Carmot Therapeutics Raises US$0.5 Million In Venture Financing 10
Amgen Enters into Licensing Agreement with Carmot Therapeutics 11
Amgen Expands its Licensing Agreement with Carmot Therapeutics 12
Genentech Enters into Licensing Agreement with Carmot Therapeutics 13
Carmot Therapeutics Inc, Key Competitors 14
Carmot Therapeutics Inc, Key Employees 15

★海外企業調査レポート[Carmot Therapeutics Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Spirig Pharma AG(製薬・医療分野):企業M&A動向
    Summary Spirig Pharma AG (Spirig Pharma) is a pharmaceutical company. The company research, develops, manufactures and markets dermatological and generic products. Its products include skin disorder products, sun protection, and solar damage products. Spirig Pharma offers products under brand names …
  • Triangle Energy (Global) Limited (TEG)(石油・ガス分野):企業M&A動向
    Summary Triangle Energy (Global) Limited (Triangle Energy) is an oil and gas exploration company. The company carries out exploration and production of oil and gas reserves in Indonesia. Its assets include Pase Field, and Reid’s Dome. Triangle Energy holds working interest and operates the Productio …
  • TiVo Corporation (TIVO):企業の財務・戦略的SWOT分析
    TiVo Corporation (TIVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Merit Medical Systems, Inc. (MMSI):企業のM&A・提携動向(医療機器分野)
    Summary Merit Medical Systems, Inc. (Merit) offers a wide variety of single-use medical devices for use in interventional and diagnostic procedures. The company’s products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolyt …
  • First Republic Bank:企業のM&A・提携・投資分析
    First Republic Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's First Republic Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Edcon Holdings (Proprietary) Limited:企業の戦略・SWOT・財務分析
    SummaryEdcon Holdings (Proprietary) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the …
  • Pattern Energy Group Inc. (PEGI):企業のM&A・提携動向(発電分野)
    Summary Pattern Energy Group Inc. (Pattern Energy), a subsidiary of Pattern Energy Group LP is an energy company that acquires and operates power projects. The company holds expertise in the construction, operation and management of energy projects. It also owns and operates sixteen wind power facil …
  • Cell Medica Limited:製品開発パイプライン動向2015
    Cell Medica Limited - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Cell Medica Limited - Product Pipeline Review - 2015’, provides an overview of the Cell Medica Limited’s pharmaceutical research and development focus. This report provides comprehensive information on the current …
  • Winbond Electronics Corporation (2344):企業の財務・戦略的SWOT分析
    Winbond Electronics Corporation (2344) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • SHS Viveon AG (SHWK):企業財務及び戦略的SWOT分析
    Summary SHS Viveon AG (SHS VIVEON) is a business and IT consulting service provider that offers customer value and customer risk management services. The company’s products comprise software products and solutions, customer interaction management, customer analytics, customer management applications …
  • Dufry AG:企業のM&A・提携・投資分析
    Dufry AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dufry AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Lazard Ltd:戦略・SWOT・企業財務分析
    Lazard Ltd - Strategy, SWOT and Corporate Finance Report Summary Lazard Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Curtiss-Wright Corp (CW):電力:M&Aディール及び事業提携情報
    Summary Curtiss-Wright Corp (Curtiss-Wright) is a manufacturing and service company. It designs, manufactures, and overhauls precision components and provides highly engineered critical function products. The company also provides support services for critical applications. Curtiss-Wright serves cus …
  • Australia and New Zealand Banking Group Limited (ANZ):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Australia and New Zealand Banking Group Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible for …
  • Petrovietnam Transportation Corporation (PVT):企業の財務及び戦略的SWOT分析
    Summary Petrovietnam Transportation Corporation (PTC), a subsidiary of Vietnam Oil and Gas Group is an oil and gas mid-stream transportation company that provides maritime transportation and services to the oil and gas industry. The company owns, operates and charters crude oil tanker, oil products …
  • IDT Corporation:企業の戦略・SWOT・財務情報
    IDT Corporation - Strategy, SWOT and Corporate Finance Report Summary IDT Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Mincor Resources NL:企業の戦略・SWOT・財務分析
    SummaryMincor Resources NL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fin …
  • Apollo Education Group, Inc.:企業の戦略・SWOT・財務情報
    Apollo Education Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Apollo Education Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • NH Hoteles S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' NH Hoteles S.A. Mergers and Acq …
  • J. Ray McDermott, S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' J. Ray McDermott, S.A. Mergers …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆